369 related articles for article (PubMed ID: 31468999)
21. Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms.
Hyun J; Lee SK; Cheon JH; Yong DE; Koh H; Kang YK; Kim MH; Sohn Y; Cho Y; Baek YJ; Kim JH; Ahn JY; Jeong SJ; Yeom JS; Choi JY
Antimicrob Resist Infect Control; 2022 Jan; 11(1):20. PubMed ID: 35093183
[TBL] [Abstract][Full Text] [Related]
22. Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation.
DuPont HL; Jiang ZD; DuPont AW; Utay NS
Dig Dis Sci; 2020 Mar; 65(3):741-756. PubMed ID: 32008133
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy analysis of fecal microbiota transplantation in the treatment of 2010 patients with intestinal disorders].
Li N; Tian HL; Chen QY; Yang B; Ma CL; Lin ZL; Zhang XY; Zhao D; Huang ZX; Jiang J; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):861-868. PubMed ID: 31550826
[No Abstract] [Full Text] [Related]
24. How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection.
Ghani R; Mullish BH; Davies FJ; Marchesi JR
Clin Microbiol Infect; 2022 Apr; 28(4):502-512. PubMed ID: 34826617
[TBL] [Abstract][Full Text] [Related]
25. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal Evaluation of Gut Bacteriomes and Viromes after Fecal Microbiota Transplantation for Eradication of Carbapenem-Resistant
Liu Q; Zuo T; Lu W; Yeoh YK; Su Q; Xu Z; Tang W; Yang K; Zhang F; Lau LHS; Lui RNS; Chin ML; Wong R; Cheung CP; Zhu W; Chan PKS; Chan FKL; Lui GC; Ng SC
mSystems; 2022 Jun; 7(3):e0151021. PubMed ID: 35642928
[TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitor in upper gastrointestinal fecal microbiota transplant: A systematic review and analysis.
Hong AS; Yu WY; Hong JM; Cross CL; Azab M; Ohning G; Jayaraj M
J Gastroenterol Hepatol; 2020 Jun; 35(6):932-940. PubMed ID: 31830335
[TBL] [Abstract][Full Text] [Related]
28. Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT)
Garza-González E; Mendoza-Olazarán S; Morfin-Otero R; Ramírez-Fontes A; Rodríguez-Zulueta P; Flores-Treviño S; Bocanegra-Ibarias P; Maldonado-Garza H; Camacho-Ortiz A
Can J Gastroenterol Hepatol; 2019; 2019():4549298. PubMed ID: 31976311
[TBL] [Abstract][Full Text] [Related]
29. Fecal microbiota transplantation beyond Clostridioides difficile infections.
Wortelboer K; Nieuwdorp M; Herrema H
EBioMedicine; 2019 Jun; 44():716-729. PubMed ID: 31201141
[TBL] [Abstract][Full Text] [Related]
30. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation.
Elangovan A; Allegretti JR; Fischer M
Expert Opin Biol Ther; 2019 Dec; 19(12):1343-1355. PubMed ID: 31570017
[No Abstract] [Full Text] [Related]
31. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria.
Battipaglia G; Malard F; Rubio MT; Ruggeri A; Mamez AC; Brissot E; Giannotti F; Dulery R; Joly AC; Baylatry MT; Kossmann MJ; Tankovic J; Beaugerie L; Sokol H; Mohty M
Haematologica; 2019 Aug; 104(8):1682-1688. PubMed ID: 30733264
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Safety of Fecal Microbiota Transplantation in Treatment of
Tun KM; Hsu M; Batra K; Lo CH; Laeeq T; Vongsavath T; Mohammed S; Hong AS
Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557703
[TBL] [Abstract][Full Text] [Related]
33. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
Girotra M; Garg S; Anand R; Song Y; Dutta SK
Dig Dis Sci; 2016 Oct; 61(10):3007-3015. PubMed ID: 27447476
[TBL] [Abstract][Full Text] [Related]
34. Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential.
Bulow C; Langdon A; Hink T; Wallace M; Reske KA; Patel S; Sun X; Seiler S; Jones S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
mSphere; 2018 Nov; 3(6):. PubMed ID: 30463925
[TBL] [Abstract][Full Text] [Related]
35. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
[TBL] [Abstract][Full Text] [Related]
36. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
37. Expert opinion on fecal microbiota transplantation for the treatment of
Kumar V; Fischer M
Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143
[No Abstract] [Full Text] [Related]
38. Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak.
Davido B; Batista R; Fessi H; Michelon H; Escaut L; Lawrence C; Denis M; Perronne C; Salomon J; Dinh A
Med Mal Infect; 2019 May; 49(3):214-218. PubMed ID: 30502308
[TBL] [Abstract][Full Text] [Related]
39. Benefits of fecal microbiota transplantation: A comprehensive review.
Ademe M
J Infect Dev Ctries; 2020 Oct; 14(10):1074-1080. PubMed ID: 33175698
[TBL] [Abstract][Full Text] [Related]
40. [Effect of intestinal preparation on the efficacy and safety of fecal microbiota transplantation treatment].
Chen QY; Tian HL; Yang B; Lin ZL; Zhao D; Ye C; Zhang XY; Qin HL; Li N
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jul; 23(Z1):48-55. PubMed ID: 32594726
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
